Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice

Human Molecular Genetics

Volumn 21, Issue 10, 2012, Pages 2263-2276

  Perronnet, Caroline ^a,b,d   Chagneau, Carine ^a,b   Le Blanc, Pascale ^a,b   Samson Desvignes, Nathalie ^a,b   Mornet, Dominique ^c   Laroche, Serge ^a,b   De la porte, Sabine ^b   Vaillend, Cyrille ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

^c UNIV MONTPELLIER   (France)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE BUTYRATE; ARGININE DERIVATIVE; BUTYRIC ACID DERIVATIVE; DYSTROPHIN; UNCLASSIFIED DRUG; UTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BRAIN; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; EMOTION; FEAR; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPATIAL MEMORY; UPREGULATION;

ANIMALS; ARGININE; BRAIN; BUTYRATES; DYSTROPHIN; MICE; MICE, INBRED MDX; MICE, KNOCKOUT; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; RNA, MESSENGER; UP-REGULATION; UTROPHIN;

MUS;

EID: 84860492770     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds047     Document Type: Article

References (89)

1. Waite, A., Tinsley, C.L., Locke, M. and Blake, D.J. (2009) The neurobiology of the dystrophin-associated glycoprotein complex. Ann. Med., 41, 344-359.
2. Desguerre, I., Christov, C., Mayer, M., Zeller, R., Becane, H.M., Bastuji-Garin, S., Leturcq, F., Chiron, C., Chelly, J. and Gherardi, R.K. (2009) Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS ONE, 4, e4347.
3. Billard, C., Gillet, P., Barthez, M., Hommet, C. and Bertrand, P. (1998) Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy. Dev. Med. Child Neurol., 40, 12-20.
4. Hinton, V.J., De Vivo, D.C., Nereo, N.E., Goldstein, E. and Stern, Y. (2000) Poor verbal working memory across intellectual level in boys with Duchenne dystrophy. Neurology, 54, 2127-2132.
5. Vaillend, C., Rendon, A., Misslin, R. and Ungerer, A. (1995) Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks. Behav. Genet., 25, 569-579.
6. Vaillend, C., Billard, J.M. and Laroche, S. (2004) Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd(mdx) mouse. Neurobiol. Dis., 17, 10-20.
7. Sekiguchi, M., Zushida, K., Yoshida, M., Maekawa, M., Kamichi, S., Sahara, Y., Yuasa, S., Takeda, S. and Wada, K. (2009) A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain, 132, 124-135.
8. Vaillend, C. and Billard, J.M. (2002) Facilitated CA1 hippocampal synaptic plasticity in dystrophin-deficient mice: role for GABAA receptors? Hippocampus, 12, 713-717.
9. Anderson, J.L., Head, S.I. and Morley, J.W. (2004) Long-term depression is reduced in cerebellar Purkinje cells of dystrophin-deficient mdx mice. Brain Res., 1019, 289-292.
10. Anderson, J.L., Morley, J.W. and Head, S.I. (2010) Enhanced homosynaptic LTD in cerebellar Purkinje cells of the dystrophic MDX mouse. Muscle Nerve, 41, 329-334.
11. Nico, B., Paola Nicchia, G., Frigeri, A., Corsi, P., Mangieri, D., Ribatti, D., Svelto, M. and Roncali, L. (2004) Altered blood-brain barrier development in dystrophic MDX mice. Neuroscience, 125, 921-935.
12. Minciacchi, D., Del Tongo, C., Carretta, D., Nosi, D. and Granato, A. (2010) Alterations of the cortico-cortical network in sensori-motor areas of dystrophin deficient mice. Neuroscience, 166, 1129-1139.
13. Miranda, R., Sebrie, C., Degrouard, J., Gillet, B., Jaillard, D., Laroche, S. and Vaillend, C. (2009) Reorganization of inhibitory synapses and increased PSD length of perforated excitatory synapses in hippocampal area CA1 of dystrophin-deficient mdx mice. Cereb. Cortex, 19, 876-888.
14. Carretta, D., Santarelli, M., Sbriccoli, A., Pinto, F., Catini, C. and Minciacchi, D. (2004) Spatial analysis reveals alterations of parvalbuminand calbindin-positive local circuit neurons in the cerebral cortex of mutant mdx mice. Brain Res., 1016, 1-11.
15. Perronnet, C. and Vaillend, C. (2010) Dystrophins, utrophins, and associated scaffolding complexes: role in Mammalian brain and implications for therapeutic strategies. J. Biomed. Biotechnol., 2010, 849426.
16. Chaubourt, E., Fossier, P., Baux, G., Leprince, C., Israel, M. and De La Porte, S. (1999) Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy. Neurobiol. Dis., 6, 499-507.
17. Anderson, J.E. (2000) A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol. Biol. Cell, 11, 1859-1874.
18. Archer, J.D., Vargas, C.C. and Anderson, J.E. (2006) Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort. FASEB J., 20, 738-740.
19. Barton, E.R., Morris, L., Kawana, M., Bish, L.T. and Toursel, T. (2005) Systemic administration of L-arginine benefits mdx skeletal muscle function. Muscle Nerve, 32, 751-760.
20. Benabdellah, F., Yu, H., Brunelle, A., Laprevote, O. and De La Porte, S. (2009) MALDI reveals membrane lipid profile reversion in MDX mice. Neurobiol. Dis., 36, 252-258.
21. Brunelli, S., Sciorati, C., D'Antona, G., Innocenzi, A., Covarello, D., Galvez, B.G., Perrotta, C., Monopoli, A., Sanvito, F., Bottinelli, R. et al. (2007) Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc. Natl Acad. Sci. USA, 104, 264-269.
22. Chazalette, D., Hnia, K., Rivier, F., Hugon, G. and Mornet, D. (2005) alpha7B integrin changes in mdx mouse muscles after L-arginine administration. FEBS Lett., 579, 1079-1084.
23. Hnia, K., Gayraud, J., Hugon, G., Ramonatxo, M., De La Porte, S., Matecki, S. and Mornet, D. (2008) L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers. Am. J. Pathol., 172, 1509-1519.
24. Marques, M.J., Luz, M.A., Minatel, E. and Neto, H.S. (2005) Muscle regeneration in dystrophic mdx mice is enhanced by isosorbide dinitrate. Neurosci. Lett., 382, 342-345.
25. Segalat, L., Grisoni, K., Archer, J., Vargas, C., Bertrand, A. and Anderson, J.E. (2005) CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy. Exp. Cell Res., 302, 170-179.
26. Voisin, V., Sebrie, C., Matecki, S., Yu, H., Gillet, B., Ramonatxo, M., Israel, M. and De la Porte, S. (2005) L-arginine improves dystrophic phenotype in mdx mice. Neurobiol. Dis., 20, 123-130.
27. Minetti, G.C., Colussi, C., Adami, R., Serra, C., Mozzetta, C., Parente, V., Fortuni, S., Straino, S., Sampaolesi, M., Di Padova, M. et al. (2006) Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med., 12, 1147-1150.
28. Guerron, A.D., Rawat, R., Sali, A., Spurney, C.F., Pistilli, E., Cha, H.J., Pandey, G.S., Gernapudi, R., Francia, D., Farajian, V. et al. (2010) Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy. PLoS ONE, 5, e11220.
29. Weir, A.P., Burton, E.A., Harrod, G. and Davies, K.E. (2002) A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle. J. Biol. Chem., 277, 45285-45290.
30. Godfrey, E.W. and Schwarte, R.C. (2003) The role of nitric oxide signaling in the formation of the neuromuscular junction. J. Neurocytol., 32, 591-602.
31. Waheed, I., Gilbert, R., Nalbantoglu, J., Guibinga, G.H., Petrof, B.J. and Karpati, G. (2005) Factors associated with induced chronic inflammation in mdx skeletal muscle cause posttranslational stabilization and augmentation of extrasynaptic sarcolemmal utrophin. Hum. Gene Ther., 16, 489-501.
32. Greenberg, D.S., Sunada, Y., Campbell, K.P., Yaffe, D. and Nudel, U. (1994) Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat. Genet., 8, 340-344.
33. Wieneke, S., Heimann, P., Leibovitz, S., Nudel, U. and Jockusch, H. (2003) Acute pathophysiological effects of muscle-expressed Dp71 transgene on normal and dystrophic mouse muscle. J. Appl. Physiol., 95, 1861-1866.
34. Cuisset, L., Tichonicky, L., Jaffray, P. and Delpech, M. (1997) The effects of sodium butyrate on transcription are mediated through activation of a protein phosphatase. J. Biol. Chem., 272, 24148-24153.
35. Davie, J.R. (2003) Inhibition of histone deacetylase activity by butyrate. J. Nutr., 133, 2485S-2493S.
36. Pilz, R.B. and Casteel, D.E. (2003) Regulation of gene expression by cyclic GMP. Circ. Res., 93, 1034-1046.
37. Hnia, K., Hugon, G., Masmoudi, A., Mercier, J., Rivier, F. and Mornet, D. (2006) Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane. Neuroscience, 141, 607-620.
38. Hnia, K., Zouiten, D., Cantel, S., Chazalette, D., Hugon, G., Fehrentz, J.A., Masmoudi, A., Diment, A., Bramham, J., Mornet, D. et al. (2007) ZZ domain of dystrophin and utrophin: topology and mapping of a beta-dystroglycan interaction site. Biochem. J., 401, 667-677.
39. Michaluk, P., Kolodziej, L., Mioduszewska, B., Wilczynski, G.M., Dzwonek, J., Jaworski, J., Gorecki, D.C., Ottersen, O.P. and Kaczmarek, L. (2007) Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity. J. Biol. Chem., 282, 16036-16041.
40. Ridnour, L.A., Windhausen, A.N., Isenberg, J.S., Yeung, N., Thomas, D.D., Vitek, M.P., Roberts, D.D. and Wink, D.A. (2007) Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclasedependent and -independent pathways. Proc. Natl Acad. Sci. USA, 104, 16898-16903.
41. Paxinos, G. and Franklin, K. (2001) The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, San Diego, CA.
42. Knuesel, I., Bornhauser, B.C., Zuellig, R.A., Heller, F., Schaub, M.C. and Fritschy, J.M. (2000) Differential expression of utrophin and dystrophin in CNS neurons: an in situ hybridization and immunohistochemical study. J. Comp. Neurol., 422, 594-611.
43. Perrine, S.P. (2008) Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. Pediatr. Ann., 37, 339-346.
44. Culligan, K., Glover, L., Dowling, P. and Ohlendieck, K. (2001) Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy. BMC Cell Biol., 2, 2.
45. Baby, S.M., Bogdanovich, S., Willmann, G., Basu, U., Lozynska, O. and Khurana, T.S. (2010) Differential expression of utrophin-A and -B promoters in the central nervous system (CNS) of normal and dystrophic mdx mice. Brain Pathol., 20, 323-342.
46. Sternlicht, M.D. and Werb, Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol., 17, 463-516.
47. Nico, B., Corsi, P., Ria, R., Crivellato, E., Vacca, A., Roccaro, A.M., Mangieri, D., Ribatti, D. and Roncali, L. (2006) Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse. Neuroscience, 140, 835-848.
48. Nico, B., Tamma, R., Annese, T., Mangieri, D., De Luca, A., Corsi, P., Benagiano, V., Longo, V., Crivellato, E., Salmaggi, A. et al. (2010) Glial dystrophin-associated proteins, laminin and agrin, are downregulated in the brain of mdx mouse. Lab. Invest., 90, 1645-1660.
49. Jimenez-Mallebrera, C., Davies, K., Putt, W. and Edwards, Y.H. (2003) A study of short utrophin isoforms in mice deficient for full-length utrophin. Mamm. Genome, 14, 47-60.
50. Lidov, H.G., Selig, S. and Kunkel, L.M. (1995) Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum. Mol. Genet., 4, 329-335.
51. Knuesel, I., Mastrocola, M., Zuellig, R.A., Bornhauser, B., Schaub, M.C. and Fritschy, J.M. (1999) Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). Eur. J. Neurosci., 11, 4457-4462.
52. Lidov, H.G., Byers, T.J., Watkins, S.C. and Kunkel, L.M. (1990) Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature, 348, 725-728.
53. Lidov, H.G., Byers, T.J. and Kunkel, L.M. (1993) The distribution of dystrophin in the murine central nervous system: an immunocytochemical study. Neuroscience, 54, 167-187.
54. Vaillend, C., Perronnet, C., Ros, C., Gruszczynski, C., Goyenvalle, A., Laroche, S., Danos, O., Garcia, L. and Peltekian, E. (2010) Rescue of a dystrophin-like protein by exon skipping in vivo restores GABAA-receptor clustering in the hippocampus of the mdx mouse. Mol. Ther., 18, 1683-1688.
55. Khurana, T.S., Watkins, S.C. and Kunkel, L.M. (1992) The subcellular distribution of chromosome 6-encoded dystrophin-related protein in the brain. J. Cell Biol., 119, 357-366.
56. Schroeder, F.A., Lin, C.L., Crusio, W.E. and Akbarian, S. (2007) Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol. Psychiatry, 62, 55-64.
57. Domek-Lopacinska, K. and Strosznajder, J.B. (2005) Cyclic GMP metabolism and its role in brain physiology. J. Physiol. Pharmacol., 56(Suppl. 2), 15-34.
58. Leibovitz, S., Meshorer, A., Fridman, Y., Wieneke, S., Jockusch, H., Yaffe, D. and Nudel, U. (2002) Exogenous Dp71 is a dominant negative competitor of dystrophin in skeletal muscle. Neuromuscul. Disord., 12, 836-844.
59. Vaillend, C., Ungerer, A. and Billard, J.M. (1999) Facilitated NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 area of dystrophin-deficient mice. Synapse, 33, 59-70.
60. Graciotti, L., Minelli, A., Minciacchi, D., Procopio, A. and Fulgenzi, G. (2008) GABAergic miniature spontaneous activity is increased in the CA1 hippocampal region of dystrophic mdx mice. Neuromuscul. Disord., 18, 220-226.
61. Vajda, Z., Pedersen, M., Doczi, T., Sulyok, E. and Nielsen, S. (2004) Studies of mdx mice. Neuroscience, 129, 993-998.
62. Nico, B., Mangieri, D., Crivellato, E., Longo, V., De Giorgis, M., Capobianco, C., Corsi, P., Benagiano, V., Roncali, L. and Ribatti, D. (2007) HIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic mdx mouse. Brain Pathol., 17, 399-406.
63. Deng, B., Glanzman, D. and Tidball, J.G. (2009) Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy. J. Physiol., 587, 1769-1778.
64. Kilgore, M., Miller, C.A., Fass, D.M., Hennig, K.M., Haggarty, S.J., Sweatt, J.D. and Rumbaugh, G. (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology, 35, 870-880.
65. Gundersen, B.B. and Blendy, J.A. (2009) Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology, 57, 67-74.
66. Sogos, V., Curto, M., Reali, C. and Gremo, F. (2002) Developmentally regulated expression and localization of dystrophin and utrophin in the human fetal brain. Mech. Ageing Dev., 123, 455-462.
67. Mejat, A., Ravel-Chapuis, A., Vandromme, M. and Schaeffer, L. (2003) Synapse-specific gene expression at the neuromuscular junction. Ann. N. Y. Acad. Sci., 998, 53-65.
68. Bogdanovich, S., Perkins, K.J., Krag, T.O. and Khurana, T.S. (2004) Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J. Mol. Med. (Berl.), 82, 102-115.
69. Gramolini, A.O., Dennis, C.L., Tinsley, J.M., Robertson, G.S., Cartaud, J., Davies, K.E. and Jasmin, B.J. (1997) Local transcriptional control of utrophin expression at the neuromuscular synapse. J. Biol. Chem., 272, 8117-8120.
70. Gramolini, A.O., Angus, L.M., Schaeffer, L., Burton, E.A., Tinsley, J.M., Davies, K.E., Changeux, J.P. and Jasmin, B.J. (1999) Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. Proc. Natl Acad. Sci. USA, 96, 3223-3227.
71. Basu, U., Gyrd-Hansen, M., Baby, S.M., Lozynska, O., Krag, T.O., Jensen, C.J., Frodin, M. and Khurana, T.S. (2007) Heregulin-induced epigenetic regulation of the utrophin-A promoter. FEBS Lett., 581, 4153-4158.
72. Corbi, N., Libri, V., Fanciulli, M., Tinsley, J.M., Davies, K.E. and Passananti, C. (2000) The artificial zinc finger coding gene 'Jazz' binds the utrophin promoter and activates transcription. Gene Ther., 7, 1076-1083.
73. Lu, Y., Tian, C., Danialou, G., Gilbert, R., Petrof, B.J., Karpati, G. and Nalbantoglu, J. (2008) Targeting artificial transcription factors to the utrophin A promoter: effects on dystrophic pathology and muscle function. J. Biol. Chem., 283, 34720-34727.
74. Tinsley, J.M., Fairclough, R.J., Storer, R., Wilkes, F.J., Potter, A.C., Squire, S.E., Powell, D.S., Cozzoli, A., Capogrosso, R.F., Lambert, A. et al. (2011) Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS ONE, 6, e19189.
75. Moorwood, C., Lozynska, O., Suri, N., Napper, A.D., Diamond, S.L. and Khurana, T.S. (2011) Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening. PLoS ONE, 6, e26169.
76. Teniente-De Alba, C., Martinez-Vieyra, I., Vivanco-Calixto, R., Galvan, I.J., Cisneros, B. and Cerecedo, D. (2011) Distribution of dystrophin- and utrophin-associated protein complexes (DAPC/UAPC) in human hematopoietic stem/progenitor cells. Eur. J. Haematol., 87, 312-322.
77. Fort, P.E., Sene, A., Pannicke, T., Roux, M.J., Forster, V., Mornet, D., Nudel, U., Yaffe, D., Reichenbach, A., Sahel, J.A. et al. (2008) Kir4.1 and AQP4 associate with Dp71- and utrophin-DAPs complexes in specific and defined microdomains of Muller retinal glial cell membrane. Glia, 56, 597-610.
78. Dalloz, C., Sarig, R., Fort, P., Yaffe, D., Bordais, A., Pannicke, T., Grosche, J., Mornet, D., Reichenbach, A., Sahel, J. et al. (2003) Targeted inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina. Hum. Mol. Genet., 12, 1543-1554.
79. Tinsley, J.M., Potter, A.C., Phelps, S.R., Fisher, R., Trickett, J.I. and Davies, K.E. (1996) Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature, 384, 349-353.
80. Dallerac, G., Perronnet, C., Chagneau, C., Leblanc-Veyrac, P., Samson-Desvignes, N., Peltekian, E., Danos, O., Garcia, L., Laroche, S., Billard, J.M. et al. (2011) Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse. Neurobiol. Dis., 43, 635-641.
81. Perrine, S.P. and Faller, D.V. (1993) Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies. Experientia, 49, 133-137.
82. Royuela, M., Chazalette, D., Hugon, G., Paniagua, R., Guerlavais, V., Fehrentz, J.A., Martinez, J., Labbe, J.P., Rivier, F. and Mornet, D. (2003) Formation of multiple complexes between beta-dystroglycan and dystrophin family products. J. Muscle Res. Cell Motil., 24, 387-397.
83. Blake, D.J., Schofield, J.N., Zuellig, R.A., Gorecki, D.C., Phelps, S.R., Barnard, E.A., Edwards, Y.H. and Davies, K.E. (1995) G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. Proc. Natl Acad. Sci. USA, 92, 3697-3701.
84. Shimada, I., Matsui, K., Iida, R., Tsubota, E. and Matsuki, T. (2009) Time course of housekeeping gene expression changes in diffuse alveolar damage induced by hyperoxia exposure in mice. Leg. Med. (Tokyo), 11(Suppl. 1), S151-S154.
85. Wilson, J., Putt, W., Jimenez, C. and Edwards, Y.H. (1999) Up71 and up140, two novel transcripts of utrophin that are homologues of short forms of dystrophin. Hum. Mol. Genet., 8, 1271-1278.
86. Rozen, S. and Skaletsky, H. (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol., 132, 365-386.
87. Pfaffl, M.W., Horgan, G.W. and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res., 30, e36.
88. Blanchard, D.C. and Blanchard, R.J. (1972) Innate and conditioned reactions to threat in rats with amygdaloid lesions. J. Comp. Physiol. Psychol., 81, 281-290.
89. Jones, M.W., Errington, M.L., French, P.J., Fine, A., Bliss, T.V., Garel, S., Charnay, P., Bozon, B., Laroche, S. and Davis, S. (2001) A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat. Neurosci., 4, 289-296.